The Chinese firm has pulled back the curtain to expose how the top labs may be building their next-generation models. Now ...

For a slew of AI chip companies chomping to dethrone Nvidia, DeepSeek is the opening they’ve been waiting for.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg ...

LinkedIn founder and venture capitalist Reid Hoffman has just launched drug discovery startup Manas AI, alongside Dr. Siddhartha Mukherjee, an oncologist.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

$540 $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

The persistent challenge of AI hallucinations - where artificial intelligence systems generate false or misleading ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Combined with the cheap valuations, the robust profitability/rich balance sheet, and DeepMind's leadership in the AI industry, we are reiterating our Buy rating for GOOG stock here. Do not miss ...

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.